Literature DB >> 19103606

Rho-kinase contributes to sustained RhoA activation through phosphorylation of p190A RhoGAP.

Kazutaka Mori1, Mutsuki Amano, Mikito Takefuji, Katsuhiro Kato, Yasuhiro Morita, Tomoki Nishioka, Yoshiharu Matsuura, Toyoaki Murohara, Kozo Kaibuchi.   

Abstract

RhoA is transiently activated by specific extracellular signals such as endothelin-1 (ET-1) in vascular smooth muscle cells. RhoGAP negatively regulates RhoA activity: thus, RhoA becomes the GDP-bound inactive form afterward. Sustained activation of RhoA is induced with high doses of the extracellular signals and is implicated in certain diseases such as vasospasms. However, it remains largely unknown how prolonged activation of RhoA is induced. Here we show that Rho-kinase, an effector of RhoA, phosphorylated p190A RhoGAP at Ser(1150) and attenuated p190A RhoGAP activity in COS7 cells. Binding of Rnd to p190A RhoGAP is thought to enhance its activation. Phosphorylation of p190A RhoGAP by Rho-kinase impaired Rnd binding. Stimulation of vascular smooth muscle cells with a high dose of ET-1 provoked sustained RhoA activation and p190A RhoGAP phosphorylation, both of which were prohibited by a Rho-kinase inhibitor. The phosphomimic mutation of p190A RhoGAP weakened Rnd binding and RhoGAP activities. Taken together, these results suggest that ET-1 induces Rho-kinase activation and subsequent phosphorylation of p190A RhoGAP, leading to prolonged RhoA activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19103606     DOI: 10.1074/jbc.M806853200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  The anaphase-promoting complex/cyclosome activator Cdh1 modulates Rho GTPase by targeting p190 RhoGAP for degradation.

Authors:  Hideaki Naoe; Kimi Araki; Osamu Nagano; Yusuke Kobayashi; Jo Ishizawa; Tatsuyuki Chiyoda; Takatsune Shimizu; Ken-ichi Yamamura; Yutaka Sasaki; Hideyuki Saya; Shinji Kuninaka
Journal:  Mol Cell Biol       Date:  2010-06-07       Impact factor: 4.272

Review 2.  Cell signaling of angiotensin II on vascular tone: novel mechanisms.

Authors:  Aurelie Nguyen Dinh Cat; Rhian M Touyz
Journal:  Curr Hypertens Rep       Date:  2011-04       Impact factor: 5.369

Review 3.  Role of rho kinase in the functional and dysfunctional tonic smooth muscles.

Authors:  Márcio A F de Godoy; Satish Rattan
Journal:  Trends Pharmacol Sci       Date:  2011-04-15       Impact factor: 14.819

4.  Antagonistic roles of PP2A-Pab1 and Etd1 in the control of cytokinesis in fission yeast.

Authors:  Aurelia Lahoz; María Alcaide-Gavilán; Rafael R Daga; Juan Jimenez
Journal:  Genetics       Date:  2010-09-27       Impact factor: 4.562

5.  Feedback regulation of SIN by Etd1 and Rho1 in fission yeast.

Authors:  María Alcaide-Gavilán; Aurelia Lahoz; Rafael R Daga; Juan Jimenez
Journal:  Genetics       Date:  2013-12-13       Impact factor: 4.562

Review 6.  Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.

Authors:  Prasanta K Hota; Matthias Buck
Journal:  Cell Mol Life Sci       Date:  2012-06-29       Impact factor: 9.261

7.  Angiotensin II type-1 receptor regulates RhoA and Rho-kinase/ROCK activation via multiple mechanisms. Focus on "Angiotensin II induces RhoA activation through SHP2-dependent dephosphorylation of the RhoGAP p190A in vascular smooth muscle cells".

Authors:  Keita Kimura; Satoru Eguchi
Journal:  Am J Physiol Cell Physiol       Date:  2009-09-09       Impact factor: 4.249

Review 8.  Involvement of Rho GTPases and their regulators in the pathogenesis of hypertension.

Authors:  Gervaise Loirand; Pierre Pacaud
Journal:  Small GTPases       Date:  2014-10-31

Review 9.  Regulation of Rho GTPase activity at the leading edge of migrating cells by p190RhoGAP.

Authors:  Aurélien Bidaud-Meynard; Fabien Binamé; Valérie Lagrée; Violaine Moreau
Journal:  Small GTPases       Date:  2017-03-13

Review 10.  New Targets in the Drug Treatment of Heart Failure.

Authors:  James A Iwaz; Elizabeth Lee; Hermineh Aramin; Danilo Romero; Navaid Iqbal; Matt Kawahara; Fatima Khusro; Brian Knight; Minal V Patel; Sumita Sharma; Alan S Maisel
Journal:  Drugs       Date:  2016-02       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.